BioRender 图标

Syringe (small, 1/2 liquid)

Syringe (small, 1/2 liquid) - Editable icon of A small syringe with 1/2 liquid filled
[{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca6d/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca6d/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca6e/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca6e/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca6f/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca6f/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca70/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca70/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca71/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca71/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca72/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca72/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca73/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca73/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca74/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca74/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca75/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca75/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca76/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca76/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca77/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca77/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca78/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca78/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca79/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca79/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca7a/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca7a/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca7b/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca7b/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca7c/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca7c/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca7d/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca7d/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca7e/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca7e/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca7f/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca7f/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca80/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca80/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca81/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca81/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca82/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca82/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca83/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca83/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca84/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca84/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca85/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca85/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca86/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca86/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca87/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca87/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca88/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca88/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca89/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca89/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca8a/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca8a/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca8b/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca8b/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca8c/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca8c/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca8d/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca8d/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca8e/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca8e/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca8f/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca8f/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca90/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca90/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca91/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca91/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca92/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca92/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca93/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca93/5f63d36a19623700288c6a7a.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍
page dashboard

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
syringe,needle,injection,inject,vaccine,vaccination,barrel,medicine,drug,gavage,needle,syringe
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Syringe (small, 1/2 liquid) icon JPEG

Syringe (small, 1/2 liquid) icon PNG

Syringe (small, 1/2 liquid) icon SVG

Syringe (small, 1/2 liquid) icon GIF

BioRender 图标常见问题解答

How are scientists using the Syringe (small, 1/2 liquid) icon in their work?

BioRender users often use the Syringe (small, 1/2 liquid) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Lab and Objects.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Syringe (small, 1/2 liquid) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Syringe (small, 1/2 liquid) icon customizable in BioRender?

Most icons in BioRender, including the Syringe (small, 1/2 liquid) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Syringe (small, 1/2 liquid) icon for publication or presentations?

Yes, figures containing the Syringe (small, 1/2 liquid) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Syringe (small, 1/2 liquid) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Syringe (small, 1/2 liquid) icon — especially those focused on Lab and Objects. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Syringe (small, 1/2 liquid) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon